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Glycoprotein B (gB) facilitates HCMV entry into cells by binding receptors and mediating membrane
fusion. The crystal structures of gB ectodomains from HSV-1 and EBV are available, but little is known
about the HCMV gB structure. Using multiangle light scattering and electron microscopy, we show here
that HCMV gB ectodomain is a trimer with the overall shape similar to HSV-1 and EBV gB ectodomains.
HCMV gB ectodomain forms rosettes similar to rosettes formed by EBV gB and the postfusion forms of
other viral fusogens. Substitution of several bulky hydrophobic residues within the putative fusion
loops with more hydrophilic residues reduced rosette formation and abolished cell fusion. We propose
that like gB proteins from HSV-1 and EBV, HCMV gB has two internal hydrophobic fusion loops that
likely interact with target membranes. Our work establishes structural and functional similarities
between gB proteins from three subfamilies of herpesviruses.
& 2012 Elsevier Inc. All rights reserved.Introduction
Herpesviruses are a large and diverse family of dsDNA, enveloped
viruses that cause lifelong, latent infections. These viruses are
classiﬁed into three subfamilies, alpha-, beta-, and gamma-, based
on their replication cycle, tropism, and other characteristics. Eight
herpesviruses from all three subfamilies are human pathogens.
Human cytomegalovirus (HCMV), a betaherpesvirus, is notable for
its extremely high prevalence in the general population as well as
the ability to cause serious infections in neonates and the immuno-
compromised (Colugnati et al., 2007).
HCMV can infect a wide range of mammalian cells (Compton and
Feire, 2007), which correlates with its ability to infect most organs
and tissues. This broad cellular tropism suggests that HCMV may
bind a number of receptors or a common surface molecule
(Compton and Feire, 2007). HCMV enters cells by fusing its envelope
with either the plasma membrane (ﬁbroblasts) (Compton et al.,
1992) or the endosomal membrane (epithelial and endothelial cells)
(Ryckman et al., 2006). HCMV initiates cell entry by attaching to the
cell surface heparan sulfate proteoglycans using envelope glycopro-
tein M (gM) or gB (Boyle and Compton, 1998; Boyle et al., 1999).
This step is followed by interaction with cell surface receptors thatll rights reserved.
eldwein).trigger entry or initiate intracellular signaling (Compton and Feire,
2007). HCMV has been reported to engage PDGFR (Soroceanu et al.,
2008) and cellular integrins (Feire et al., 2004), probably through
their interaction with gB (Feire et al., 2004; Soroceanu et al., 2008).
In support of this, a disintegrin-like consensus sequence, an integrin-
binding motif, was recently identiﬁed within residues 92–111 of
HCMV gB (Feire et al., 2004) and shown to interact with a b1
integrin domain (Feire et al., 2010). EGFR, initially reported to be
necessary for HCMV cell entry (Wang et al., 2003), was subsequently
shown not to be important for either viral entry or HCMV-induced
signaling (Isaacson et al., 2007).
Interaction of gB with PDGFR and integrins probably engages
cellular signaling pathways instead of directly participating in viral
entry because gB expression does not interfere with entry into either
epithelial cells or ﬁbroblasts (Ryckman et al., 2008). The entry
receptor function might instead be provided by gH/gL glycoprotein
complexes. Different gH/gL complexes are known to facilitate entry
into epithelial cells, endothelial cells, or ﬁbroblasts. While entry into
ﬁbroblasts requires gH/gL heterodimer (Wille et al., 2010), entry into
epithelial and endothelial cells requires the pentameric complex gH/
gL/UL128/UL130/UL131 (or gH/gL/UL128–131) (Ryckman et al.,
2006), in addition to gH/gL (Ryckman et al., 2010; Wille et al.,
2010). Expression of gH/gL/UL128–131 complex, but not gH/gL, in
epithelial cells causes cells to become resistant to HCMV infection
(Ryckman et al., 2008), which suggests that gH/gL/UL128–131
complex binds HCMV receptor on epithelial cells. By contrast, HCMV
Fig. 1. Schematic view of the full-length HCMV gB and constructs used in this work. SS—signal sequence, MP—membrane-proximal region, TM—transmembrane region,
Cyto—cytoplasmic domain. Eighteen predicted N-linked glycosylation sites are shown as lollipops.
S. Sharma et al. / Virology 435 (2013) 239–249240infection of ﬁbroblasts can be blocked by co-expression of gH/gL and
gO (Vanarsdall et al., 2011) but not gH/gL/UL128–131. Thus,
different gH/gL complexes engage distinct entry receptors on
epithelial/endothelial cells and ﬁbroblasts, but these have not yet
been identiﬁed.
Receptor engagement is followed by membrane fusion, a process
mediated by gB and gH/gL. Early antibody studies have supported
critical roles for both gB and gH/gL in HCMV entry (Britt, 1984;
Cranage et al., 1986; Simpson et al., 1993; Urban et al., 1996). gB is
essential for entry and cell spread, as shown by studies on an HCMV
gB-null mutant in ﬁbroblasts (Isaacson and Compton, 2009). gB and
gH/gL are necessary and sufﬁcient for cell fusion (Vanarsdall et al.,
2008) and thus constitute the ‘‘core fusion machinery’’ of HCMV,
which is conserved among other herpesviruses (Eisenberg et al.,
2012). HCMV gB and gH/gL can mediate fusion either in cis (from
the same membrane) or in trans (from opposing membranes)
(Vanarsdall et al., 2008), which has also been observed for HSV-1
(Atanasiu et al., 2010). The precise fusion trigger in HCMV has not yet
been identiﬁed. Receptor binding by gH/gL/UL128–131 probably does
not trigger fusion because the expression of gH/gL/UL128–131 does
not block cell fusion (Vanarsdall et al., 2008). Alternatively, receptor
binding by gH/gL/UL128–131 functions as a fusion trigger only during
endosomal entry but not entry at the plasma membrane or cell
fusion.
Relatively little is known about the speciﬁc role of gB in HCMV
entry and cell fusion apart from its requirement for both processes
and its engagement of cellular signaling receptors. By contrast, more
mechanistic details are available for homologous gB proteins from
HSV-1, an alphaherpesvirus, and EBV, a gammaherpesvirus. Crystal
structures of gB from HSV-1 (Heldwein et al., 2006) and EBV
(Backovic et al., 2009) revealed strong protein fold similarities
between the two ectodomains (Connolly et al., 2011) despite low
sequence identity (25.9%) and provided important functional
insights. gB proteins are structurally similar to the viral fusion
proteins from unrelated viruses, vesicular stomatitis virus G (VSV
G) and baculovirus gp64, both of which are necessary and sufﬁcient
for viral entry and cell fusion. This structural similarity, in the
absence of any sequence similarity, implicated gB as the fusion
protein of herpesviruses capable of undergoing large conformational
changes to effect fusion (Heldwein et al., 2006). Together, HSV-1 gB,
EBV gB, VSV G, and gp64 formed a new class of viral fusion proteins,
class III, that is distinct from class I, exempliﬁed by inﬂuenza
hemagglutinin, and class II, represented by ﬂavivirus envelope
protein E (Harrison, 2008; Steven and Spear, 2006).
Structural similarity with VSV G helped pinpoint the location of
the two putative fusion loops in HSV-1 gB (Heldwein et al., 2006).
Mutations of speciﬁc residues in these loops abolished fusion
(Hannah et al., 2009, 2007) as well as interaction with model
membranes (liposomes) (Hannah et al., 2009), providing biochemical
and functional evidence for the possible involvement of theseresidues in fusion, most likely in membrane insertion. Hydrophobic
residues in fusion loops in EBV gB were shown to be necessary for
fusion (Backovic et al., 2007a) and also responsible for the formation
of rosettes by the recombinant EBV gB ectodomain (Backovic et al.,
2007b). Such rosette formation has been observed with the ectodo-
mains of several viral fusion proteins, e.g., inﬂuenza hemagglutinin
(Ruigrok et al., 1988) and SFV E1 (Gibbons et al., 2004) whereby the
exposed hydrophobic fusion peptides or loops interacted, causing
aggregation. Finally, unlike gH/gL that can participate in fusion as a
soluble protein, gB has to be membrane anchored (Atanasiu et al.,
2010), which is consistent with it being a fusion protein. Taken
together, these data support the hypothesis that HSV-1 and EBV gB
are viral fusion proteins.
By comparison, little structural and mechanistic information is
available on HCMV gB. Its ectodomain shares 24.2% sequence
identity with HSV-1 gB and 30.3% with EBV gB. Previously, the
ectodomain of HCMV gB was expressed in insect cells and shown
to be proteolytically processed and to react with conformational
antibodies (Carlson et al., 1997), justifying its use in functional
experiments. However, no additional structural characterization
has been carried out, and it remains unclear to what extent HCMV
gB resembles its alpha- and gammaherpesvirus counterparts.
Here we show that the HCMV gB ectodomain is a trimer with
an overall architecture resembling the ectodomains of HSV-1 and
EBV gB, which supports the idea that gB proteins from all three
herpesvirus subfamilies share similar structures. The ectodomain
of HCMV gB forms rosette-like aggregates, similar to rosettes
formed by the EBV gB ectodomain. By generating and analyzing a
homology model of HCMV gB ectodomain based on HSV-1 gB
structure (Heldwein et al., 2006), we identiﬁed four exposed
hydrophobic residues within the putative fusion loops, Y155,
I156, Y157, and W240. Substitution of these residues with their
more hydrophilic HSV-1 counterparts reduced rosette formation
and abolished cell fusion. We propose that HCMV gB has two
internal hydrophobic fusion loops, functionally similar to those of
HSV-1 and EBV gB, that are required for membrane fusion.
Together with the structural information, these results support
the hypothesis that gB is the fusion protein of HCMV. Our ﬁndings
establish structural and functional similarities between gB proteins
from three different herpesvirus subfamilies.Results
Expression and puriﬁcation of recombinant HCMV
gB ectodomain
All gB ectodomain constructs were expressed in insect cells
infected by recombinant baculoviruses. Initially, three gB constructs
Fig. 2. Properties of the HCMV gB706-CHis6. (A) Coomassie-stained gels and a
Western blot of puriﬁed HCMV gB706-CHis6. Under non-reducing mildly denatur-
ing conditions (BME, unboiled), the protein migrates as a mixture of monomer
and trimer. Under reducing denaturing conditions (þBME, boiled), some protein
migrates as an intact monomer while a fraction separates into the N-terminal and
C-terminal fragments. O—oligomer, M—monomer, N—N-terminal fragment,
C—C-terminal fragment. Molecular size standards are labeled. (B) Size-exclusion
chromatogram of puriﬁed gB706-CHis6. gB elutes as a broad peak near the void
volume. The elution volumes of the void and the 667 kDa standard are shown
(arrows). (C) Electron micrograph of puriﬁed gB706-CHis6. Arrows indicate long
rods (D, dimer of trimers) and three-armed particles (T, trimer of trimers).
Close-up view of selected rods and three-armed particles is shown below. Pink
asterisks mark crown ends. (D) Electron micrograph of HSV-1 gB730 along with its
crystal structure, in surface representation. Pink asterisks mark crown ends, and
blue asterisks mark fusion-loop-containing base ends.
S. Sharma et al. / Virology 435 (2013) 239–249 241were created, all encoding the mature ectodomain of HCMV (strain
AD169) gB, residues 25–706 , with a honeybee melittin signal
sequence and either an N-terminal His6 tag, a C-terminal His6 tag,
or no tag (Fig. 1). All constructs lacked the hydrophobic membrane-
proximal region, the transmembrane region, and the cytoplasmic
domain. HCMV gB residues 25–706 correspond to the HSV-1 gB
residues 31–730 . Previously expressed version of the HCMV gB
ectodomain, residues 1–692 , was shorter and contained a
C-terminal His6 tag yet could not be puriﬁed using metal afﬁnity
chromatography (Carlson et al., 1997). HCMV gB residue 692
corresponds to HSV-1 gB residue 715, which is buried in the crystal
structure (Heldwein et al., 2006; Stampfer et al., 2010), so a His6 tag
immediately following this residue would not be fully exposed. To
avoid this problem, our constructs were extended to residue 706,
which corresponds to HSV-1 gB residue 730.
Initially, His6-tagged gB706 proteins were puriﬁed using metal
afﬁnity chromatography. Due to poor protein purity and yield, we
switched to immunoafﬁnity puriﬁcation with the mAb 27–39 , which
recognizes a conformational epitope within the oligomeric form of
the HCMV gB ectodomain (Britt and Vugler, 1992). Subsequent size-
exclusion chromatography yielded pure HCMV gB ectodomain
(Fig. 2A). Purity and yield, 10–20 mg from 1 l of insect cell super-
natant, were highest with gB706-CHis 6, and it was used in
subsequent work.
HCMV gB is proteolytically processed into disulﬁde-linked
N and C termini
HCMV gB contains a furin cleavage site, RTRR, residues 456–459
(Figs. 1 and 3). In cells infected with HCMV or transfected with a
plasmid encoding HCMV gB, the 160 kDa precursor is cleaved into
an N-terminal product of 116 kDa and a C-terminal product of
58 kDa, albeit incompletely (Britt and Vugler, 1989; Vey et al.,
1995). gB incorporated into HCMV virions is likewise incompletely
processed (Britt, 1984). Since insect cells express furin-like proteases
(Cieplik et al., 1998), we tested if HCMV gB ectodomain expressed in
insect cells underwent proteolytic processing by analyzing puriﬁed
gB706-CHis 6 protein by SDS-PAGE in the presence or absence of the
reducing agent, beta-mercaptoethanol (BME).
In the absence of BME, gB706-CHis 6 migrated as a 120–
130 kDa band, consistent with a monomer, as well as a higher MW
species (Fig. 2A). In contrast, in the presence of BME, we observed
two additional bands migrating at 70 kDa and 35 kDa (Fig. 2A).
The 35-kDa band reacted with a mAb 27–156 (Fig. 2A), which
recognizes antigenic domain 1 (AD-1) (Spaete et al., 1988), the
dominant antibody-binding site within residues 552–635 of HCMV
gB (Britt et al., 2005; Wagner et al., 1992). Thus, the 70 kDa and
the 35-kDa bands corresponded to the N- and C-terminal fragments,
respectively. The smaller size of the C-terminal fragment in the
gB706-CHis 6 relative to the virion gB is due to the absence of
residues 707–906 while the smaller size of the N-terminal fragment
can be explained by the presence of less complex carbohydrate
chains used by insect cells to modify glycoproteins (Jarvis, 2003).
Similar results were previously obtained with HCMV gB692-CHis 6
expressed in TN5 insect cells (Carlson et al., 1997). The recombinant
HCMV gB ectodomain expressed in insect cells is processed similarly
to the gB incorporated into HCMV virions, although with a lower
efﬁciency. Lower efﬁciency of furin cleavage, probably due to low
levels of endogenous furin, has been observed with other glycopro-
teins expressed in insect cells (Cieplik et al., 1998).
HCMV gB ectodomain forms rosette-like aggregates
Recombinant gB ectodomains from HSV-1 and EBV are tri-
meric (Backovic et al., 2009; Heldwein et al., 2006). HCMV gB692-
CHis 6 was reported to migrate as a dimer on a mildly denaturingSDS-PAGE (Carlson et al., 1997). Likewise, we found that under
non-reducing, mildly denaturing conditions, approximately half
of gB706-CHis 6 migrated as a high-molecular-weight band
(Fig. 2A). Under similar conditions, the trimeric HSV-1 gB ecto-
domain also migrates as an apparent dimer (Silverman et al.,
2010; Stampfer et al., 2010). This seeming anomaly is probably
Fig. 3. Sequence alignment of gB proteins from HSV-1 (strain KOS), EBV (strain B958), and HCMV (strain AD169), generated using ClustalW2 (Larkin et al., 2007). Residue
numbers for HSV-1 gB and HCMV gB are shown above and below their respective sequences. Secondary structure of HSV-1 gB is shown above the sequence alignment, and
its coloring matches that in reference (Heldwein et al., 2006). Signal sequences, absent from mature glycoproteins, are shown in red. Identical residues are highlighted in
yellow; similar residues, in gray; cysteines, in green; and putatively glycosylated asparagines, in blue. Furin cleavage sites in HCMV and EBV are highlighted in purple.
Residues in two fusion loop regions are shown in teal. Figure was generated in ALSCRIPT (Barton, 1993). (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article.)
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Fig. 4. Fusion loop regions in HCMV gB and HSV-1 gB ectodomains. (A) Crystal
structure of HSV-1 gB ectodomain, gB730, is shown side-by-side with a homology
model of HCMV gB ectodomain, gB706, in surface representations. Fusion loop regions
are shown in side and face-on views. Hydrophobic residues (yellow), positively charged
residues (blue), negatively charged residues (red) and histidines (cyan) are shown. Side
chains of mutated residues in HCMV gB706-4M mutant and their HSV-1 counterparts
are labeled (in one protomer only, for clarity). Figures were generated using PyMol
(/www.pymol.orgS). (B) Sequence alignment of the fusion loop regions in HCMV gB,
HCMV gB706-4M mutant, HSV-1 gB, and EBV gB. Hydrophobic residues (orange),
positively charged residues (blue), negatively charged residues (red), and histidines
(cyan) are colored. Mutated residues in HCMV gB and their HSV-1 gB counterparts are
underlined. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
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mation of the molecular size based on electrophoretic mobility.
Unfortunately, we could not assess the oligomeric state of the
HCMV ectodomain in solution using size-exclusion chromatogra-
phy because the protein aggregated and eluted as a broad double
peak near the void volume (Fig. 2B).
To gain insight into the nature of oligomerization and aggrega-
tion of the HCMV gB ectodomain, we examined the puriﬁed gB706-
CHis 6 samples using negative-stain electron microscopy (EM). We
observed primarily long rods and three-armed particles (Fig. 2C),
plus occasional rosettes with four or ﬁve arms. The length of each
arm in the three-armed particles, 16.971.3 nm (n¼6), was con-
sistent with the length of HSV-1 gB ectodomain calculated from its
atomic coordinates (16.7 nm) (Heldwein et al., 2006) or measured
from EM images (16.1 nm) (Stampfer et al., 2010). Thus, each arm
was likely composed of one ectodomain, such that the three-armed
particle contained three ectodomains. The long rods were
34.271.5 nm (n¼5) in length, approximately twice as long as the
HSV-1 gB ectodomain, and were likely formed by two ectodomains
joined end-to-end . The characteristic ‘‘crown’’ shape at the tip of
each arm in the three-armed particles and at both ends of the long
rods (Fig. 2C) resembled the ‘‘crown’’ end of the HSV-1 gB730
molecule (Fig. 2D) (Heldwein et al., 2006; Silverman et al., 2010;
Stampfer et al., 2010). Both three-armed particles and long rods
appear to associate by the ‘‘base’’ ends, which in HSV-1 and EBV gB
contain the fusion loops.
Fusion loops (and fusion peptides) are important functional
regions in viral fusion proteins. Typically rich in aromatic and
hydrophobic residues, fusion loops are thought to insert into target
cellular membranes during fusion. Exposed hydrophobic fusion
loops in the postfusion forms of several viral fusion proteins can
lead to the formation of rosette-like aggregates (Gibbons et al., 2004;
Ruigrok et al., 1988). In these rosettes, ectodomains are associated
by their fusion loop regions (Gibbons et al., 2004; Ruigrok et al.,
1988). EBV gB ectodomain also forms rosettes that depend on
interactions between the hydrophobic fusion loops (Backovic et al.,
2007b). Speciﬁcally, replacement of hydrophobic residues WY112–113
and WLIW193–196 in fusion loops 1 and 2 of EBV gB with their less
hydrophobic HSV-1 gB counterparts HR and RVEA, respectively,
abolished rosette formation (Backovic et al., 2007b) and allowed
crystallization (Backovic et al., 2009). In contrast to EBV gB, HSV gB
ectodomain does not aggregate (Heldwein et al., 2006) (Fig. 2D);
nevertheless, the fusion loops of HSV-1 gB enable liposome associa-
tion (Hannah et al., 2009). Since HCMV gB rosette-like particles were
reminiscent of the rosettes formed by EBV gB ectodomain and by
the ectodomains of other viral fusion proteins, we hypothesized that
the putative fusion loops of HCMV gB were involved in rosette
formation.
Formation of HCMV gB rosette-like aggregates is mediated by
hydrophobic residues within the fusion loops
The putative fusion loops of HCMV gB, YAYIYT153–158 and
GSTWLYRE237–244, contain several hydrophobic residues
(Figs. 3 and 4). To identify surface-exposed hydrophobic residues
within the fusion loops, we generated a homology model of HCMV gB
ectodomain (Fig. 4) using the structure of HSV-1 gB730 (Heldwein
et al., 2006). Residues YIY155–157 andW240 were prominently exposed
on the surface of the HCMV gB706 homology model (Fig. 4A). To
determine their role in rosette formation, we substituted residues
YIY155–157 and W240 with their less hydrophobic HSV-1 gB counter-
parts GHR and A, respectively (Figs. 1and 4B), generating gB706-4M
mutant (Y155G/I156H/Y157R/W240A).
The gB706-4M mutant ectodomain was expressed and puriﬁed
in the same way as the WT gB706-CHis 6, but its yield was
signiﬁcantly higher, 500 mg from 1 l of insect cells. Like the WTectodomain, the mutant migrated as an oligomer on a mildly
denaturing SDS-PAGE and was partially processed into disulﬁde-
linked N- and C-terminal fragments (Fig. 5A). N-terminal sequencing
of the C-terminal fragment revealed the sequence STSDNN, which
matched the sequence following the furin cleavage site. This result
unequivocally conﬁrmed that the HCMV gB ectodomain was cleaved
at the furin site during expression in insect cells.
On a size-exclusion column, gB706-4M eluted as two peaks
(Fig. 5B). Peak 1 eluted in the void volume of the column and
contained aggregated protein while peak 2 eluted in the same
volume as the monodisperse HSV-1 gB730 and likely contained
the monodisperse gB706-4M protein (Fig. 5B). In support of this,
negative-stain EM revealed that peak 1 contained rosette-like
aggregates, mostly long rods but also three-armed particles, plus
an occasional short rod (Fig. 5C). By contrast, peak 2 contained
only short rods, 17.870.8 nm (n¼4) in length, representing
monodisperse gB706-4M ectodomains (Fig. 5C).
Thus, replacement of several hydrophobic residues in the
putative fusion loop regions with neutral or charged residues
prevented aggregation of the HCMV gB ectodomain. This ﬁnding
conﬁrmed that the rosette-like aggregates of HCMV gB were held
together by interactions between hydrophobic residues in the
fusion loop regions.
Hydrophobic residues in fusion loops are necessary
for cell fusion
The importance of residues Y155, I156, Y157, and W240 for
rosette formation suggested that they might be necessary for
fusion. To evaluate their contribution to fusion directly, we tested
the gB-4M mutant in an established adenovirus transduction cell
Fig. 5. Properties of the quadruple mutant gB706-4M. (A) Coomassie-stained gel of puriﬁed gB706-4M. Under non-reducing mildly denaturing conditions (BME,
unboiled), the protein migrates as a mixture of monomer and trimer. Under non-reducing denaturing conditions (BME, boiled), the protein migrates as a monomer.
Under reducing denaturing conditions (þBME, boiled), some protein migrates as an intact monomer while a fraction separates into the N-terminal and C-terminal
fragments. O—oligomer, M—monomer, N—N-terminal fragment, C—C-terminal fragment. Molecular size standards are labeled. (B) Overlay of size-exclusion
chromatograms of WT HCMV gB706-CHis6, HCMV gB706-4M mutant, and HSV-1 gB730. The elution volumes of the void and the 667 kDa and 232 kDa standards are
marked with arrows. (C) Electron micrographs of peaks 1 and 2 with different particles marked with arrows: long rods (D, dimer of trimers), three-armed particles
(T, trimer of trimers), and a single short rod (M, monodisperse trimer). (D) Close-up views of individual particles in HCMV gB706-4M, peak 2 and HSV-1 gB730. The crystal
structure of HSV-1 gB730 in surface representation is shown for comparison. Pink asterisks mark crown ends, and blue asterisks mark fusion-loop containing base ends.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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introduced into HCMV TR gB, generating mutant gB-4M (Y156G/
I157H/H158R/W241A, TR numbering). Unlike the WT HCMV TR
gB, the gB-4M mutant did not mediate any cell fusion of ARPE-19
cells in the presence of gH/gL (Fig. 6A). Lack of fusion was not due
to insufﬁcient surface expression because surface expression level
of the gB-4M mutant was comparable to the expression level of
the WT HCMV TR gB, as detected by cell-based ELISA (Fig. 6B). The
gB-4M mutant also became largely endoglycosidase H resistant in
a similar fashion to the WT gB (data not shown), conﬁrming that
this mutant gB passed ER quality control. Thus, substitution of
four residues in the putative fusion loops abrogated fusion with-
out affecting the expression or the trafﬁcking of the mutant to the
cell surface. On the basis of these observations, we propose that
residues 153–158 and 237–244 constitute functional fusion loops
in HCMV gB, with residues Y155, I156, Y157, and W240 (AD169
numbering) likely playing important roles in fusion.HCMV gB ectodomain is a trimer
Monodisperse HCMV gB706-4M particles were very similar to
those of trimeric HSV-1 gB730 in both their length and shape
(Fig. 5D). Moreover, the mutant eluted in the same volume as the
HSV-1 gB730 on a size-exclusion column (Fig. 5B), suggesting that
like HSV-1 gB ectodomain, the HCMV gB ectodomain is trimeric.
To determine the oligomeric state of HCMV gB706-4M
directly, we used multi-angle light scattering (MALS). This tech-
nique is independent of molecular shape and can be used to
determine molecular weight of non-globular proteins. HSV-1
gB730, a known trimer, was used as a control. The precise
molecular weights of the glycosylated HSV-1 gB730 and HCMV
gB706-4M polypeptides were determined by MALDI-TOF mass
spectrometry. The experimentally determined molecular weight
of HSV-1 gB730 was 85.6 kDa, larger than that calculated from
its amino acid sequence 78.8 kDa due to glycosylation of six
Fig. 6. gB-4M mutant does not mediate cell fusion despite adequate surface
expression. (A) SYTO 13 green ﬂuorescent nucleic acid staining was used to
quantify fusion of ARPE-19 cells mediated by either WT gB or gB-4M mutant, in
the presence of gH/gL. The level of fusion was quantiﬁed by counting the total
number of cell nuclei in syncytia divided by the total number of nuclei in the same
ﬁeld and expressed as the percentage of cells fused. A syncytium was deﬁned as
such when membrane enclosed 10 or more nuclei. Reported values represent an
average of three experiments. (B) Surface expression in HDFn cells of WT gB and
gB-4M mutant was assessed by cell-based ELISA with the mAb 27–156. Non-
speciﬁc binding of the antibody to cells was measured with cells infected with
recombinant adenovirus encoding Tet transactivator instead of gB. In each
experiment, the Tet transactivator control was subtracted from the sample. Six
replicate samples were averaged, and the signal was expressed as a percentage of
WT (100%). Error bars represent standard deviations. Relatively large standard
deviations are likely due to the fact that at any time, only a small fraction of total
HCMV gB is present on the cell surface, especially when compared to HSV gB or
HCMV gB lacking the endocytic motif within the cytoplasmic domain (data not
shown).
Fig. 7. HCMVgB706-4M is a trimer in solution. SEC-coupled multi-angle light
scattering (MALS) analysis of HSV-1 gB730 (A) and HCMV gB706-4M (B) is shown.
The signal from the 901-scattering detector is shown in black and the signal from
the refractive index detector is shown in red; both are plotted against the left
Y-axis. Average molecular weights are plotted in blue against the right Y-axis.
Molecular weight corresponding to that of a trimer is shown as a horizontal
dashed black line. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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weight of the HSV-1 gB730 ectodomain in solution, as determined
by MALS, was 266.1 kDa (Fig. 7A), which is consistent with a
trimer. The experimentally determined molecular weight of
HCMV gB706-4M polypeptide was 101.3 kDa, larger than the
calculated molecular weight of 78.4 kDa. The difference of
22.9 kDa suggested that all 18 predicted N-linked glycosylation
sites were glycosylated (Fig. 3). The molecular weight of HCMV
gB706-4M ectodomain in solution, as determined by MALS, was
300.3 kDa (Fig. 7B), which corresponds to a trimer. Thus, the
HCMV gB ectodomain is a trimer like HSV-1 and EBV homologs.Discussion
HCMV gB shares structural similarities with gB proteins
from HSV-1 and EBV
gB is a key entry protein of HCMV, yet very little is known
about its structure and its speciﬁc role in HCMV entry. Here, we
carried out a detailed biochemical characterization of the HCMVgB ectodomain. The recombinant HCMV gB ectodomain expressed
in insect cells was proteolytically cleaved and glycosylated
similarly to virion HCMV gB and was used to investigate the
structural and biochemical properties of HCMV gB. We obtained
direct evidence that HCMV gB ectodomain is a trimer and that its
overall structure resembles the ectodomains of HSV-1 and EBV
gB. This novel ﬁnding demonstrates that despite relatively low
sequence identity, the three proteins share fundamentally similar
structures. More detailed structural comparisons await the crystal
structure of HCMV gB.
HCMV gB has functional fusion loops
We found that HCMV gB ectodomain formed rosette-like
aggregates associated by its presumed fusion loop regions. By
generating and analyzing a homology model of HCMV gB706,
based on the crystal structure of HSV-1 gB730 (Heldwein et al.,
2006), we identiﬁed several exposed hydrophobic residues in the
putative fusion loops. Replacement of the most prominently
exposed residues Y155, I156, Y157, and W240 with their hydro-
philic HSV-1 counterparts signiﬁcantly decreased aggregation,
suggesting that these residues confer the ability to form rosettes
on HCMV gB ectodomain. The propensity of HCMV gB ectodomain
to aggregate via its fusion loop regions resembles EBV gB and is
S. Sharma et al. / Virology 435 (2013) 239–249246consistent with both proteins containing multiple hydrophobic
residues within these loops. Due to aggregation of the WT HCMV
gB ectodomain, we were unable to test its ability to associate with
membranes or to evaluate the effect of fusion loop mutations on
this ability. Instead, we tested the importance of these four
residues for cell fusion. The quadruple mutant gB-4M was unable
to mediate cell fusion despite adequate surface expression, con-
ﬁrming the importance of mutated residues for fusion. Analogous
substitutions within the fusion loops of EBV gB eliminated rosette
formation (Backovic et al., 2007b) and abrogated its fusion
activity (Backovic et al., 2007a). We propose that HCMV gB has
two functional fusion loops and that residues Y155, I156, Y157,
and W240 are necessary for fusion. Future work will assess
individual contributions of these residues to fusion.
Possible role of hydrophobic residues in HCMV gB fusion
loops in fusion
Fusion loops, found in class II and class III viral fusion proteins,
are typically rich in aromatic and hydrophobic residues. Fusion
loops insert into and perturb the outer leaﬂet of the target cellular
membranes thereby facilitating membrane fusion. Aromatic resi-
dues are thought to play an essential role in the destabilization of
the outer leaﬂet because they position themselves at an interface
between the hydrocarbon side chains and the polar head groups.
In VSV G, three aromatic residues in fusion loops are required for
fusion (Sun et al., 2008). The fusion loops of EBV gB contain four
aromatic residues (Backovic et al., 2007a). Residues W174 and
Y179 within relatively hydrophilic fusion loops of HSV-1 gB are
critical for fusion (Hannah et al., 2007). Therefore, we anticipate
that all aromatic residues within HCMV gB fusion loops will be
essential for fusion, likely for insertion into the target membrane.
The recombinant HCMV gB ectodomain likely adopts
the postfusion conformation
The conformation adopted by the recombinant gB ectodo-
mains from HSV-1, EBV, and HCMV probably represents the
postfusion form. Indeed, the structures of HSV-1 and EBV gB
ectodomains more closely resemble the extended postfusion
rather than the globular prefusion structure of VSV G. Also, in
both structures, the fusion loops are located in proximity to the C
termini leading into the transmembrane region, which is a typical
feature of the postfusion forms of all other fusion proteins.
Therefore, we conclude that like HSV-1 and EBV gB, the HCMV
gB ectodomain expressed in insect cells adopts the trimeric
postfusion conformation. Of course, the structure of the prefusion
form of gB is necessary to deﬁnitively conﬁrm this. By analogy
with other viral fusion proteins, gB is hypothesized to undergo
large-scale refolding during fusion, although evidence for refold-
ing has not yet been obtained. The recombinantly expressed gB
ectodomain adopts the postfusion conformation whereas on the
viral envelope or on cell surface gB is presumably in its prefusion
conformation. Thus, any future work with the HCMV gB ectodo-
main should take into account the fact that the conformation of
the recombinantly expressed gB ectodomain may differ from that
of the full-length, membrane-bound gB.
gB is the likely fusion protein of HCMV
The most conserved among herpesvirus entry glycoproteins,
gB is thought to be the fusion protein of HSV and EBV. Here we
showed that HCMV gB ectodomain shares overall structure with
the HSV-1 gB ectodomain and that several residues in its fusion
loops mediate rosette formation and are necessary for fusion.
These results support the hypothesis that gB is the fusion proteinof HCMV. Taken together, our ﬁndings establish structural and
functional similarities between gB proteins from three different
herpesvirus subfamilies.Materials and methods
Cloning and mutagenesis
To generate the ﬁrst HCMV gB ectodomain expression construct,
DNA encoding the mature ectodomain of HCMV (strain AD169) gB,
residues 25–706 , was ampliﬁed using forward primer 50-
CGCGGATCCGTCTTCTAGTACTTCCCATGC-30, BamHI site italicized,
and reverse primer 50-CGCGGTACCTCAGGGCGGTAGCGGGTCGACTA-
30, KpnI site italicized. The resulting PCR product was cloned into the
BamHI and KpnI-digested pFastBac1 vector (Invitrogen) modiﬁed to
contain melittin signal sequence to generate plasmid pKH74, which
encodes HCMV gB706. To generate gB706 with a C-terminal His6 tag,
PCR product was generated using forward primer 50-CGCGCGCATAT-
GAAAAATACGGAAACGTGTC-30, NdeI site italicized, reverse primer
50-CGCAAGCTTTCAATGGTGATGGTGATGGTGGGTACCGGGCGGTAGCG-
GGTCGACTA-30, HindIII site italicized, and pKH74 plasmid as a
template. This product was subcloned into the NdeI and HindIII-
digested pKH74 plasmid yielding plasmid pKH75 encoding gB706-
CHis 6. To generate gB706 with an N-terminal His6 tag, PCR product
was generated using forward primer 50-CGCGGATCCGCACCATC-
ACCATCACCATGGTACTAGTTCTTCTAGTACTTCCCATGC-30, BamHI site
italicized, reverse primer 50-CGCGCGCATATGTTTGATTGTATGAAGTA-
TTG-30, NdeI site italicized, and pKH74 plasmid as a template. This
product was subcloned into the BamHI and NdeI-digested pKH74
plasmid yielding plasmid pKH76 encoding gB706-NHis 6.
To generate the quadruple mutant gB ectodomain, Y155G/I156H/
Y157R/W240A (gB706-4M), mutation W240A was ﬁrst introduced
into pKH74 plasmid by site-directed mutagenesis using forward
primer 50-GGCAGCACCGCGCTCTATCGTGAGACCTGT-30 and reverse
primer 50-ACAGGTCTCACGATAGAGCGCGGTGCTGCC-30, generating
plasmid pSS1. Three mutations Y155G/I156H/Y157R were then
introduced simultaneously by splicing-by-overlap-extension PCR
(SOE-PCR) method. Forward primer 50-CGGTCTAGAACCATGAAA-
TTCTT-30, XbaI site italicized, and reverse primer 50-GCAGATAA-
GTGGTGCGGTGGCCAGCGTAGCTACG-30 were used to generate the
50 SOE PCR fragment. Forward primer 50-CGTAGCTACGCTGGCCACCG-
CACCACTTATCTGC-30 and reverse primer 50-CGCGCATATGTTTGATTG-
TAT-30, NdeI site italicized, were used to generate the 30 SOE PCR
fragment. The resulting SOE-PCR product was subcloned into XbaI
and NdeI-digested plasmid pSS1 to yield plasmid pSS2 encoding
HCMV gB706-4M mutant.
All clones were sequenced and veriﬁed to contain the correct
reading frame and appropriate sequences. Due to the cloning
strategy, all mature proteins contain two extra residues (DP) at
the N terminus. The His6 tag was left out from the gB706-4M
construct because it was not necessary for immunoafﬁnity
puriﬁcation.
The full-length HCMV gB-4M mutant was generated by the
SOE-PCR method using the entire HCMV gB (strain TR) gene as a
template. Three PCR fragments were made separately using three
primer pairs: 50-AAAAAATCTAGAATGGAATCCAGGATCTGGTGCC-30
(XbaI site italicized) and 50-GCAGATAAGTGGTGCGGTGGCCAGCG-
TAGCTACG-30; 50-CGTAGCTACGCTGGCCACCGCACCACTTATCTGC-
30 and 50-ACAGGTCTCACGATAGAGCGCGGTGCTGCC-30; and 50-
GGCAGCACCGCGCTCTATCGTGAGACCTGT-30 and 50-AAAAAACTC-
GAGTCAGACGTTCTCTTCTTCGTCAGAG-3’ (XhoI site italicized). The
three PCR fragments were spliced together, and the resulting PCR
product was subcloned into XbaI and XhoI-digested pCAGGS
vector to yield plasmid pSS3 encoding HCMV TR gB-4M mutant,
Y156G/I157H/H158R/W241A. The plasmid also has an additional,
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from the pSS3 plasmid and inserted into plasmid pCMV-SPORT6
(Invitrogen).
Antibodies
Hybridoma cell lines expressing anti-HCMV gB mAbs 27–39 or
27–156 were a gift from William J. Britt (University of Alabama).
The mAbs were puriﬁed at the GRASP facility at Tufts Medical
Center. 27-39 is a conformational mAb that recognizes the
oligomeric form of HCMV gB ectodomain (Britt and Vugler,
1992). 27-156 recognizes antigenic domain 1 (AD-1) (Spaete
et al., 1988), the dominant antibody-binding site within HCMV
gB that maps to residues 552–635 (Wagner et al., 1992).
Viruses and cells
Spodoptera frugiperda (Sf9) cells were grown in SF-900 II SFM
(Invitrogen) in suspension at 27 1C. Trichoplasia Ni (HiFive) cells
were grown in Express Five SFM (Invitrogen). Recombinant
baculoviruses of all HCMV gB ectodomain constructs were gen-
erated using Bac-to-Bac technology (Invitrogen). After two rounds
of ampliﬁcation, passage 3 (P3) stocks of baculoviruses were
harvested and stored at 4 1C in the dark and in the presence of
2% Fetal Bovine Serum (FBS, Invitrogen). Human retinal pigmen-
ted epithelial (ARPE-19) cells were obtained from ATCC and
grown in DMEM/F-12 medium (Hyclone) in the presence of 10%
FBS (Hyclone). Human dermal ﬁbroblasts (HDFn, Invitrogen) were
grown in DMEM (HyClone) containing 10% FBS, 5% Bovine Growth
Serum Supplemented Calf (HyClone), 3 mM glutamine, and peni-
cillin/streptomycin. 911 retinoblastoma cells were maintained in
DMEM containing 10% FBS and penicillin/streptomycin.
Protein expression and puriﬁcation
For protein expression, P3 stocks of baculoviruses were used to
infect Sf9 or Hi5 cells. The amount of viral inoculum was
optimized to yield the highest protein expression. Both Sf9 and
Hi5 cells were tested, but Sf9 cells yielded a higher expression of
all constructs and were used for all subsequent expression.
Typically, 10 mL of viral stock was added to 1 L of SF9 cells at
2106 cells/mL, and cell supernatants were harvested 72 h post-
infection . Cells were pelleted using centrifugation at 3750 rpm at
4 1C for 20 min. The supernatant was collected, ﬁltered through a
0.45 mm ﬁlter, and concentrated using a Tangential Flow Filtration
system (Millipore) using a 30-kDa PLTK cartridge (Millipore).
Buffer exchange was done three times into phosphate-buffered
saline, pH 7.4, to remove media components. 1 mM benzamidine
and 0.1 mM PMSF were added to the extract to inhibit proteolytic
activity.
The gB ectodomain constructs, gB706-CHis 6, gB706-NHis 6,
and the gB706-4M mutant were puriﬁed using immunoafﬁnity
chromatography using mAb 27–39 coupled to a CNBr-activated
Sepharose 4B (GE Healthcare). After extensive washing with
10 mM Tris (pH 8.0) and 500 mM NaCl, the protein was eluted
with 3 M KSCN and concentrated on an Amicon Ultra-15 concen-
trator (Millipore) with a 30-kDa MW cutoff.
The protein was further puriﬁed by size-exclusion chromato-
graphy using Superdex S200 column (GE Healthcare) equilibrated
with 20 mM Tris (pH 8.0), 150 mM NaCl, and 1 mM EDTA. The
column was calibrated using blue dextran (2000 kDa), thyr-
oglobulin (667 kDa), ferritin (440 kDa), catalase (232 kDa), and
aldolase (158 kDa). The ﬁnal yield of gB706-CHis 6 and gB706-4M
was 10–20 mg and 500 mg, respectively, from 1 L of insect cell
supernatant.HSV-1 gB730 was puriﬁed as described previously (Heldwein
et al., 2006; Stampfer et al., 2010).SDS-PAGE and western blot
Three conditions were used in preparation of samples for SDS-
PAGE: mildly denaturing (0.1% SDS, no reducing agent, no boil-
ing), non-reducing denaturing (1% SDS, no reducing agent, boil-
ing), and reducing denaturing (1% SDS, reducing agent, boiling).
For Western blot, proteins were resolved by SDS-PAGE (4–15%
acrylamide gel, Bio-Rad) and transferred onto nitrocellulose
membrane. The membrane was blocked with 5% skimmed milk
in Tris-buffered saline containing 0.05% Tween-20 and probed
with mAb 27–156 at 1:1000 dilution. Following incubation with
secondary antibody, anti-mouse IgG conjugated to horseradish
peroxidase, at a 1:10,000 dilution, and blots were developed using
HRP substrate chemiluminescence kit (Bio-Rad).Electron microscopy
Puriﬁed protein samples of gB706-CHis 6 and gB706-4M
constructs (5 mg/mL) were incubated on glow-discharged for-
mvar/carbon-coated 200 mesh copper grids (SPI) at room tem-
perature and stained with 0.75% solution of uranyl formate. EM
images were obtained using a Tecnai G2 Spirit BioTWIN transmis-
sion electron microscope at the Harvard Medical School EM core
facility.N-terminal sequencing
For N-terminal sequencing, protein samples were resolved
by a 4–15 % SDS-PAGE and transferred to a PVDF membrane.
The membrane was stained with Coomassie R-250 . The protein
bands of interest were cut out and submitted for sequencing by
Edman degradation at the Tufts University Core Facility.Mass spectrometry
For mass spectrometry analysis, the HSV-1 gB730 and HCMV
gB706-4M proteins were analyzed using sinapinic acid (Agilent
Technologies, US) as matrix. MS measurements were performed
on a Voyager DE-Pro MALDI-TOF Mass Spectrometer (Applied
Biosystems).Size-exclusion chromatography (SEC)-coupled multiangle
light scattering (MALS)
For SEC-coupled MALS, the HSV-1 gB730 and HCMV gB706-4M
proteins (2.6 mg/mL and 1.5 mg/mL injected concentration)
were subjected to SEC using Superose 6 column (GE Healthcare)
equilibrated overnight in 20 mM Tris (pH 8.0), 300 mM NaCl, and
1 mM EDTA. The chromatography system was connected in line
to a DAWN Heleos II light-scattering instrument equipped with a
658 nm laser and Optilab T-rEX interferometric refractometer
(Wyatt Technology). Data were analyzed with ASTRA 6 software
(Wyatt Technology), yielding the molar mass and mass distribu-
tion (polydispersity) of the sample. Due to glycosylation, the data
were analyzed using the protein conjugate analysis option within
ASTRA 6 software. To account for glycosylation, the dn/dc value of
0.13 mL/g was used instead of 0.185 mL/g, which is used for
unmodiﬁed proteins. For normalization of the light scattering
detectors and data quality control, monomeric BSA was used.
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Homology model of HCMV gB ectodomain, gB706, was gener-
ated using standard protocols in the Modeller software (Eswar
et al., 2006) and the crystal structure of HSV-1 gB ectodomain,
gB730 (PDB ID 2GUM), as the template.Preparation of recombinant replication-defective adenovirus
HCMV TR gB-4M in pCMV-SPORT6 was used for BP-mediated
recombination (Invitrogen) with the Adeno-X-ccdB bacterial arti-
ﬁcial chromosome (BAC) according to manufacturer’s instruc-
tions. After in-vitro recombination, BAC DNA was electroporated
into DH10B bacterial cells, and bacteria selected using chloram-
phenicol and ampicillin. Individual bacterial colonies were
screened for the presence of recombinant sequences by restric-
tion analysis of extracted BAC DNA with BsrGI. Puriﬁed BAC DNA
was linearized with PacI (New England Biolabs), and the resulting
adenovirus vector encoding HCMV TR gB-4M was transfected into
911 retinoblastoma cells using calcium phosphate method. Trans-
fected cells were monitored for 4–6 days for the presence of
adenovirus-induced cytopathic effect, at which point cells were
harvested and sonicated to obtain total cell lysates containing
infectious adenovirus. The recombinant adenovirus encoding
HCMV TR gB-4M was titered on 911 retinoblastoma cells as
described previously (Vanarsdall et al., 2008).Cell–cell fusion assay
ARPE-19 cells were infected with recombinant adenoviruses
encoding HCMV TR gH, gL, and either WT gB or gB-4M mutant at
30 pfu/cell in growth media containing 2% FBS. Cells were con-
comitantly infected with a recombinant adenovirus supplying the
Tet transactivator, required to activate protein expression, at one-
ﬁfth of the total PFU. At 4 h post-infection, virus was removed and
cells washed twice with growth media, then incubated in growth
media at 37 1C for additional 24–60 h. To assess the level of
fusion, cells were ﬁxed in PBS containing 2% formaldehyde,
permeabilised with PBS containing 0.2% Triton X-100, and stained
with a 5 mm stock of SYTO 13 green ﬂuorescent nucleic acid stain
(Invitrogen) diluted 1:20,000 in PBS. Images were captured on
Nikon Eclipse TS100 microscope ﬁtted with a Qiacam digital CCD
camera. The level of fusion was quantiﬁed by counting the total
number of cell nuclei in syncytia divided by the total number of
nuclei in the same ﬁeld and expressed as the percentage of cells
fused. A syncytium was deﬁned as such when one ﬂuorescent
membrane enclosed 10 or more nuclei.Cell-based ELISA assay
HDFn cells were seeded at 2104 cells per well of a 96 well
plate. The following day, cells were infected with adenoviral
vector encoding WT gB or gB-4M mutant at 100 pfu/cell in media
containing 2% FBS. Six hours post-infection, the cells were washed
twice and low serum media was replaced. Forty-eight hours post-
infection, mAb 27–156 was added to the cells in media containing
2% donkey serum at 4 1C. Cells were incubated with the antibody
for 2 h at 4 1C, washed extensively with cold PBSþ/þ , then ﬁxed
with 4% PFA in PBSþ/þ for 1 h at 4 1C. After rehydration in PBSþ/
þ , the samples were incubated with donkey anti-mouse HRP
(Jackson ImmunoResearch) for 30 min at RT, washed, and TMB
substrate (Sigma) was added. Reaction was stopped with the
addition of 2 M H2SO4 and plates read in a SpectraMAX190
(Molecular Devices) at 450 nm.Author contributions
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